yohimbine has been researched along with Ischemia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Liu, B; Wei, J; Zhou, J | 1 |
| Brothers, RM; Christmas, KM; Diller, KR; Khoshnevis, S; Patik, JC | 1 |
| Akcay, F; Calik, M; Cetin, N; Gundogdu, C; Ingec, M; Isaoglu, U; Kurt, A; Polat, B; Suleyman, H; Yilmaz, M | 1 |
| Bruehl, S; Burns, JW; Chung, OY; Diedrich, L | 1 |
| Agrawal, DK; Cavallari, N; Edwards, JD; McGregor, PE; Mingoli, A; Sapienza, P | 1 |
| Allain, H; Bentué-Ferrer, D | 1 |
| Fujimura, S; Horikoshi, A; Kondo, T; Matsumura, Y; Okada, Y; Shimada, K | 1 |
| Donello, JE; Gil, DW; Padillo, EU; Webster, ML; Wheeler, LA | 1 |
| Davis, TR; Vanhoutte, PM; Wood, MB | 1 |
| Blondin, P; Bordes, LR; Soubeyrand, L | 1 |
| Duchamps, B | 1 |
| Klein, R | 1 |
1 review(s) available for yohimbine and Ischemia
| Article | Year |
|---|---|
Clinical efficacy of almitrine-raubasine. An overview.
Topics: Aged; Aging; Almitrine; Clinical Trials as Topic; Cognition Disorders; Drug Combinations; Humans; Ischemia; Neuroprotective Agents; Retinal Vessels; Treatment Outcome; Yohimbine | 1998 |
2 trial(s) available for yohimbine and Ischemia
| Article | Year |
|---|---|
Trait anger expressiveness and pain-induced beta-endorphin release: support for the opioid dysfunction hypothesis.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adult; Anger; beta-Endorphin; Chronic Disease; Female; Hot Temperature; Humans; Ischemia; Low Back Pain; Male; Pain Measurement; Pain Threshold; Pressure; Yohimbine | 2007 |
[Study of Iskedyl in otoneurologic ischemia].
Topics: Audiometry; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Combinations; Ear, Inner; Ergoloid Mesylates; Female; Humans; Ischemia; Male; Otorhinolaryngologic Diseases; Yohimbine | 1974 |
9 other study(ies) available for yohimbine and Ischemia
| Article | Year |
|---|---|
Dexmedetomidine Ameliorated Cognitive Dysfunction Induced by Intestinal Ischemia Reperfusion in Mice with Possible Relation to the Anti-inflammatory Effect Through the Locus Coeruleus Norepinephrine System.
Topics: Adrenergic Antagonists; Animals; Anti-Inflammatory Agents; Benzylamines; Cognitive Dysfunction; Dexmedetomidine; Eosine Yellowish-(YS); Hematoxylin; Ischemia; Locus Coeruleus; Malondialdehyde; Mice; Neuroprotective Agents; Neurotoxins; Norepinephrine; Reperfusion; Reperfusion Injury; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase; Yohimbine | 2022 |
Pronounced and sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of neurotransmitters released from sympathetic nerves.
Topics: Administration, Cutaneous; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Arginine; Blood Vessels; Cryotherapy; Female; Humans; Ischemia; Leg; Male; Microdialysis; Propranolol; Receptors, Adrenergic, alpha; Receptors, Neuropeptide Y; Skin; Time Factors; Vasoconstriction; Yohimbine | 2018 |
An investigation about the inhibition of acute ischemia/reperfusion damage by dexmedetomidine in rat ovarian tissue.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Biomarkers; Dexmedetomidine; DNA Damage; Female; Glutathione; Guanine; Ischemia; Lipid Peroxidation; Malondialdehyde; Ovary; Protective Agents; Rats; Rats, Wistar; Reperfusion Injury; Yohimbine | 2013 |
Ischemia-induced peripheral arterial vasospasm role of alpha 1- and alpha 2-adrenoceptors.
Topics: Animals; Dogs; Femoral Artery; Ischemia; Male; Methoxamine; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Radioligand Assay; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vasoconstriction; Yohimbine | 1996 |
Alpha-adrenergic blockade in preventing posttransplant edema of lung allograft.
Topics: Adrenergic alpha-Antagonists; Animals; Drug Evaluation, Preclinical; Heart Failure; Hemodynamics; Ischemia; Ligation; Lung; Lung Transplantation; Male; Prazosin; Pulmonary Artery; Pulmonary Circulation; Pulmonary Edema; Rats; Rats, Inbred BUF; Sympathectomy, Chemical; Vascular Resistance; Yohimbine | 1999 |
alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aspartic Acid; Brimonidine Tartrate; Chromatography, Liquid; Electroretinography; Extracellular Space; Glutamic Acid; Ischemia; Male; Mass Spectrometry; Quinoxalines; Rats; Rats, Inbred BN; Retina; Retinal Ganglion Cells; Retinal Vessels; Vitreous Body; Yohimbine | 2001 |
The effect of hypothermic ischemia on the alpha-adrenergic mechanisms of the canine tibia vascular bed.
Topics: Animals; Blood Vessels; Dogs; Dose-Response Relationship, Drug; Hypothermia; In Vitro Techniques; Ischemia; Norepinephrine; Perfusion; Pressure; Receptors, Adrenergic, alpha; Regional Blood Flow; Tibia; Yohimbine | 1992 |
[Evaluation of the activity of duxil in the endocochlear hypoacusis of ischemic origin].
Topics: Adult; Aged; Almitrine; Audiometry; Cochlea; Drug Combinations; Evoked Potentials, Auditory; Female; Hearing Disorders; Humans; Ischemia; Labyrinth Diseases; Male; Middle Aged; Piperazines; Yohimbine | 1988 |
[Value of electroretinography in the objective evaluation of tissue circulation therapy].
Topics: Anisoles; Catechols; Drug Combinations; Electroretinography; Ethanol; Evaluation Studies as Topic; Humans; Ischemia; Middle Aged; Piperazines; Retinal Degeneration; Retinal Diseases; Retinal Vessels; Yohimbine | 1972 |